Status:

UNKNOWN

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Lead Sponsor:

University of Oulu

Collaborating Sponsors:

University of Helsinki

Conditions:

Intracerebral Hemorrhage

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

* To evaluate the efficacy of using IPC during the acute phase of ICH in the prevention of VTE. * To assess the safety and efficacy of additional therapy with enoxaparin. * To compare the efficacy and...

Detailed Description

* Although it has been poorly investigated, the risk of VTE among patients with acute primary intracerebral hemorrhage is generally believed to be at least as high as among patients with ischemic stro...

Eligibility Criteria

Inclusion

  • acute primary ICH
  • \> 17 years
  • unable to walk
  • admitted within 12 h after onset of ICH
  • informed consent obtained

Exclusion

  • other type of ICH than acute primary intracerebral hemorrhage
  • patients who need neurosurgery
  • evidence of VTE at screening
  • thrombolytic treatment within the preceding week
  • major surgery or major trauma within the preceding 3 months
  • life expectancy less than 3 months due to comorbid disorders
  • confirmed malignant disease (cancer)
  • hepatitis and/or liver cirrhosis
  • renal failure
  • infectious disease (HIV, endocarditis etc.)
  • current of previous hematologic disease
  • recent active and untreated gastric/duodenal ulcer
  • allergy or known hypersensitivity to enoxaparin or heparins
  • known hypersensitivity to benzyl alcohol
  • women of childbearing age if pregnant
  • participation in another study within the preceding 30 days

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2013

Estimated Enrollment :

320 Patients enrolled

Trial Details

Trial ID

NCT00699465

Start Date

August 1 2008

End Date

December 1 2013

Last Update

July 2 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neurology, Oulu University Hospital

Oulu, Finland, 90029 OYS